Literature DB >> 3883815

The pharmacological treatment of delusional depression.

D G Spiker, J C Weiss, R S Dealy, S J Griffin, I Hanin, J F Neil, J M Perel, A J Rossi, P H Soloff.   

Abstract

The authors investigated the pharmacological treatment of delusional depression by assigning patients on a random double-blind basis to amitriptyline alone, perphenazine alone, or a combination of the two. Fourteen (78%) of the 18 patients assigned to amitriptyline plus perphenazine were responders, compared with seven (41%) of 17 patients treated with amitriptyline alone and three (19%) of the 16 patients treated with perphenazine alone. The combination of amitriptyline and perphenazine was clearly superior (p less than .01).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3883815     DOI: 10.1176/ajp.142.4.430

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  38 in total

Review 1.  Bipolar depression: management options.

Authors:  Gin S Malhi; Philip B Mitchell; Shahzad Salim
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  [Therapy resistance to antidepressants. Definition, prevalence, predictors, and interventional possibilities].

Authors:  H-J Möller
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

Review 3.  Tailoring adult psychiatric practices to the field of geriatrics.

Authors:  B S Greenwald; N Kremen; P Aupperle
Journal:  Psychiatr Q       Date:  1992

Review 4.  Psychotic major depression: a benefit-risk assessment of treatment options.

Authors:  Audrey R Tyrka; Lawrence H Price; Marcelo F Mello; Andrea F Mello; Linda L Carpenter
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 5.  State of the science on psychosocial interventions for ethnic minorities.

Authors:  Jeanne Miranda; Guillermo Bernal; Anna Lau; Laura Kohn; Wei-Chin Hwang; Teresa LaFromboise
Journal:  Annu Rev Clin Psychol       Date:  2005       Impact factor: 18.561

Review 6.  [Delusional depression : Diagnostics, phenomenology and therapy].

Authors:  M Bürgy
Journal:  Nervenarzt       Date:  2017-05       Impact factor: 1.214

7.  [Psychotic and quasi-psychotic atypical experiences in Puerto Rican depressed adolescents: Prevalence and related factors].

Authors:  Yaritza M López Robledo; Eduardo Cumba-Avilés; Guillermo Bernal
Journal:  Interam J Psychol       Date:  2009

Review 8.  Antidepressive effects of traditional and second generation antipsychotics: a review of the clinical data.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-04       Impact factor: 5.270

Review 9.  A risk-benefit assessment of pharmacotherapies for clinical depression in children and adolescents.

Authors:  J Renaud; D Axelson; B Birmaher
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

10.  Measuring treatment response in psychotic depression: the Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account.

Authors:  Søren D Østergaard; Barnett S Meyers; Alastair J Flint; Benoit H Mulsant; Ellen M Whyte; Christine M Ulbricht; Per Bech; Anthony J Rothschild
Journal:  J Affect Disord       Date:  2014-01-02       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.